Concepedia

Rubén Fernández‐Rodríguez

RF

Statistics

Publications

11

Citations

641

H-Index

11

Active since

2010

Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research(Current)

Icahn School of Medicine at Mount Sinai

Vall d'Hebron Institute of Oncology

Hospital Universitario de La Princesa

Rubén Fernández‐Rodríguez is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2010–2022

11

Publications

11

PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation

María Isabel Rodríguez, Andreína Peralta-Leal, Francisco O′Valle et al. · PLoS Genetics · 2013 · 132 citations · Full text

, , +17

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Bérengère Salomé, John P. Sfakianos, Daniel Ranti et al. · Cancer Cell · 2022 · 127 citations · Full text

, , +13

Acquired hepatocerebral degeneration: clinical characteristics and MRI findings

Rubén Fernández‐Rodríguez, Alejandro Contreras, Juan Guzmán de Villoria et al. · European Journal of Neurology · 2010 · 83 citations

, , +14

3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine

Cristina C. Clement, Angelo D’Alessandro, Sangeetha Thangaswamy et al. · Nature Communications · 2021 · 62 citations · Full text

, , +16

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer

Anita Rogic, Ila Pant, Luca Grumolato et al. · Nature Communications · 2021 · 57 citations · Full text

, , +17

1–5 of 11